Marshall Anderson
Affiliations: | University of Cincinnati, Cincinnati, OH |
Area:
Toxicology, Molecular Biology, OncologyGoogle:
"Marshall Anderson"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Musolf AM, Simpson CL, Moiz BA, et al. (2021) Genetic variation and recurrent haplotypes on chromosome 6q23-25 risk locus in familial lung cancer. Cancer Research |
Musolf AM, Moiz BA, Sun H, et al. (2019) Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p and 4q. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology |
Liu Y, Lusk CM, Cho MH, et al. (2018) Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
Byun J, Schwartz AG, Lusk C, et al. (2018) Genome-Wide Association Study of Familial Lung Cancer. Carcinogenesis |
Musolf AM, Simpson CL, de Andrade M, et al. (2017) Parametric Linkage Analysis Identifies Five Novel Genome-Wide Significant Loci for Familial Lung Cancer. Human Heredity. 82: 64-74 |
Musolf AM, Simpson CL, de Andrade M, et al. (2017) Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies. Genes. 8 |
Xiong D, Wang Y, Kupert E, et al. (2015) A recurrent mutation in PARK2 is associated with familial lung cancer. American Journal of Human Genetics. 96: 301-8 |
Karim NA, Bui H, Pathrose P, et al. (2014) The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer. Clinical Medicine Insights. Oncology. 8: 139-44 |
Liu P, Morrison C, Wang L, et al. (2012) Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis. 33: 1270-6 |
Starnes SL, Pathrose P, Wang J, et al. (2012) Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer. The Annals of Thoracic Surgery. 93: 1606-12 |